Answers are grounded in this paper and cite their sources.
Megavoltage radiotherapy was used as a treatment in 218 patients with supraglottic cancer. Forty-five percent had positive nodes and 43% had extralaryngeal disease. Absolute 3- and 5-year survival for T1-T2 was 70 and 60%; for T3-T4 lesions it was 42 and 35%. Differences in survival between patients with negative nodes and those with mobile nodes was unremarkable. One percent recurred in the neck when there was no palpable node initially. Ninety-five percent of mobile nodes were controlled when the primary was cured. The most common failure site was the larynx. Neither subglottic extension nor specific sites of extralaryngeal involvement worsened the prognosis. Eight had major radiation complications, 1 fatal, 7 requiring tracheotomy. Twenty-five had surgery for recurrence, and 7 were salvaged. Our present policy is radiotherapy for early tumors, and for T4, if more than total laryngectomy is required. Surgery is reserved for radiation failure and often for advanced disease limited to larynx.
No takes yet. Share an insight, caveat, or question.
Bataini et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: